While it's not the first lawsuit, Shapiro said this one is the most wide-ranging, specifically detailing how Purdue Pharma's sprawling sales force stormed doctors' offices and pharmacies, making more than 500,000 visits since 2007.
The complaint alleges Purdue Pharma "took advantage of addiction to make money." Shapiro contends the company misinformed doctors about the addictive nature of OxyContin. All the while, Purdue made more than $35 billion in revenue.
Opioid makers and distributors are facing increasing legal and financial consequences. Several municipalities and states are suing individually, contending that the companies ignored warning signs that people were taking opioids for reasons other than their intended use.
More than 1,600 separate cases have been consolidated by a federal judge in Cleveland.
Purdue Pharma recently agreed to pay the state of Oklahoma $270 million rather than face trial on charges of misleading marketing practices and misrepresentation regarding its main product.